Lifestyle
- Regular exercise
- Stress management
- Avoid smoking
- Adequate hydration
Platelets · PLT · Blutplättchen
Platelet count measures the number of platelets in the blood, which are critical for blood clotting and wound repair.
Reference ranges may vary slightly based on laboratory standards and patient demographics.
Platelets, also known as thrombocytes, are small, anucleate cell fragments derived from megakaryocytes in the bone marrow. They play a crucial role in hemostasis, the process that stops bleeding by forming clots, and are involved in thrombosis, which can lead to pathological clot formation. Platelets are activated in response to vascular injury, where they adhere to the site of damage, aggregate with other platelets, and facilitate the formation of a stable clot by providing a surface for coagulation factor complexes. Researchers have identified subpopulations of platelets, such as procoagulant platelets, which expose phosphatidylserine to enhance coagulation. Clinically, platelet counts are essential for diagnosing and managing conditions like thrombocytopenia, where low platelet levels can lead to excessive bleeding, and thrombocytosis, which may indicate an increased risk of thrombotic events. Elevated platelet counts can signal conditions such as inflammation, infection, or malignancy, while low counts may be due to bone marrow disorders, increased destruction, or drug-induced immune responses. In athletic performance and biohacking, maintaining optimal platelet function is crucial for recovery and injury prevention, as platelets are involved in tissue repair and inflammation modulation. However, platelet counts can be influenced by various factors, including medications, nutritional status, and underlying health conditions, which should be considered when interpreting results. Time of day and fasting status typically do not significantly affect platelet counts, but acute stress or recent intense exercise can alter results. Therefore, consistent testing conditions are recommended for accurate monitoring.
Klinische Bedeutung
Elevated platelet counts may indicate conditions like inflammation, thrombocytosis, or cancer, while reduced counts can suggest thrombocytopenia, bone marrow disorders, or drug-induced platelet destruction.
Progressively rising platelet counts may suggest inflammation or a myeloproliferative disorder. Retest in 4 weeks if elevated.
Progressively falling platelet counts may indicate bone marrow suppression or increased destruction.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant dietary or lifestyle changes, especially if underlying health conditions are present.
Platelet counts may vary with circadian rhythms; testing at the same time of day is recommended for consistency.
Testing Frequency
Annually for routine health checks, more frequently if monitoring a specific condition.
Current research suggests that there is no consensus on the exact definition and markers for procoagulant platelets, creating challenges in establishing reference ranges and optimal targets for clinical use. Researchers have not yet established the clinical significance of reticulated platelets in various conditions beyond thrombocytopenia and chemotherapy recovery. Additionally, unanswered clinical questions remain regarding the role of platelet aggregation in adverse pregnancy outcomes and the specific mechanisms of platelet-cancer interactions in pancreatic cancer.
616
Total Citations
9
Human/RCT
2.8
Avg. Influence
2025
Latest
Researchers discussed the characteristics and functions of procoagulant platelets, proposing a unified terminology for this platelet subpopulation. The review emphasizes their potential as biomarkers for thrombotic events and the therapeutic targeting of these platelets to improve treatment outcomes.
Researchers conducted a systematic review on the impact of platelet storage duration on clinical outcomes. The findings suggest that while fresh platelets may improve certain transfusion metrics, storage time does not significantly affect mortality or bleeding events in critically ill or hematology patients.
Researchers explored the role of platelets in venous thromboembolism (VTE), suggesting that they may be more significant in VTE than previously thought. The review discusses mechanisms linking platelets to VTE and evaluates antiplatelet therapies as potential preventive measures.
Researchers examined the role of platelet microparticle-associated microRNAs in hemostasis and inflammation. The study highlights their potential in intercellular signaling and suggests that these microRNAs could serve as biomarkers in cardiovascular diseases and cancer.
Researchers reviewed the clinical applications and limitations of measuring reticulated platelets, which are more reactive than mature platelets. The study highlights the need for standardized measurement techniques and discusses their potential use in diagnosing and assessing various clinical conditions.
Researchers compiled evidence on reticulated platelets (RPs), which are immature platelets that indicate bone marrow activity. The study suggests that measuring RPs can help differentiate causes of thrombocytopenia and predict platelet recovery after treatments like chemotherapy. More clinical studies are needed to confirm their significance in various conditions.
Researchers summarized the complex interactions between platelets and pancreatic cancer, highlighting how tumor cells can enhance platelet aggregation and contribute to thrombosis. The review discusses the potential of these interactions as biomarkers and therapeutic targets in pancreatic cancer treatment.
Researchers found that procoagulant platelets, a distinct subpopulation of platelets, play a crucial role in coagulation and thrombus stabilization. Reduced levels are linked to bleeding disorders, while elevated levels are associated with thrombotic conditions, including stroke recurrence. The study highlights the need for standardized assays to measure these platelets in clinical settings.
This systematic review compared laboratory parameters between multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease. Researchers found that MIS-C patients had lower platelet counts compared to Kawasaki disease patients, indicating potential differences in disease mechanisms. The findings may assist clinicians in differentiating between these two conditions.
Su Xiaoling & Zhao Weixiu · Clinica chimica acta; international journal of clinical chemistry · 2022
Researchers found that platelet aggregation is significantly higher in normal pregnancies compared to nonpregnant controls. The study established a reference range for platelet aggregation during pregnancy and identified correlations with hemoglobin and platelet counts. These findings suggest that platelet aggregation may be influenced by physiological changes in pregnancy.
Key findings
Research publications about Thrombozyten over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer